EUVIMEDEUVIMED entdecken
Crossref

Baicalin facilitates remyelination and suppresses neuroinflammation in rats with chronic cerebral hypoperfusion by activating Wnt/β-catenin and inhibiting NF-κB signaling

Yining Xiao, Tianyuan Guan, Xiaofeng Yang, Jing Xu, Jiawei Zhang, Qianqian Qi, Zhenjie Teng, Yanhong Dong, Yaran Gao, Meixi Li, Nan Meng, Peiyuan Lv

Behavioural Brain Research · 2023-03 · 442 · 114301

DOI: 10.1016/j.bbr.2023.114301 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Behavioural Brain Research, 2023-03. Verfasst von Yining Xiao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hebei Medical University, Shijiazhuang 050017, China; Department of Neurology, Hebei General Hospital, Shijiazhuang 050051, …. Hauptthemen laut MEDLINE: Brain Ischemia, Dementia, Vascular, Demyelinating Diseases, Remyelination. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 60 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One main factor contributing to the cognitive loss in vascular dementia (VD) is white matter lesions (WMLs) carried on by chronic cerebral hypoperfusion (CCH). A secondary neuroinflammatory response to CCH accelerates the loss and limits the regeneration of oligodendrocytes, leading to progressive demyelination and insufficient remyelination in the white matter. Thus, promoting remyelination and inhibiting neuroinflammation may be an ideal therapeutic strategy. Baicalin (BAI) is known to exhibit protective effects against various inflammatory and demyelinating diseases. However, whether BAI has neuroprotective effects against CCH has not been investigated. To determine whether BAI inhibits CCH-induced demyelination and neuroinflammation, we established a model of CCH in rats by occluding the two common carotid arteries bilaterally. Our results revealed that BAI could remarkably ameliorate cognitive impairment and mitigate CA1 pyramidal neuron damage and myelin loss. BAI exhibited enhancement of remyelination by increasing the expression of myelin basic protein (MBP) and oligodendrocyte transcription factor 2 (Olig2), inhibiting the loss of oligodendrocytes and promoting oligodendrocyte regeneration in the corpus callosum of CCH rats. Furthermore, BAI modified microglia polarization to the anti-inflammatory phenotype and inhibited the release of pro-inflammatory cytokines. Mechanistically, BAI treatment significantly induced phosphorylation of glycogen synthase kinase 3β (GSK3β), enhanced the expression of β-catenin and its nuclear translocation. Simultaneously, BAI reduced the expression of nuclear NF-κB. Collectively, our results suggest that BAI ameliorates cognitive impairment in CCH-induced VD rats through its pro-remyelination and anti-inflammatory capacities, possibly by activating the Wnt/β-catenin and suppressing the NF-κB signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain IschemiaDementia, VascularDemyelinating DiseasesRemyelinationAnimalsRatsAnti-Inflammatory Agentsbeta CateninNeuroinflammatory DiseasesNF-kappa BWnt Signaling PathwayFlavonoids

Stichwörter der Autor:innen

BaicalinChronic cerebral hypoperfusionNF-κBNeuroinflammationRemyelinationWnt/β-catenin

Substanzen

Anti-Inflammatory Agentsbeta CateninNF-kappa BbaicalinFlavonoids

Autor:innen und Institutionen

  • Department of Neurology, Hebei Medical University, Shijiazhuang 050017, China; Department of Neurology, Hebei General Hospital, Shijiazhuang 050051, China; Hebei Provincial Key Laboratory of Cerebral Networks and Cognit…
  • Department of Neurology, Hebei Medical University, Shijiazhuang 050017, China; Department of Neurology, Hebei General Hospital, Shijiazhuang 050051, China.
  • Department of Neurology, Hebei Medical University, Shijiazhuang 050017, China; Department of Pediatric Surgery, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.
  • Department of Neurology, Hebei General Hospital, Shijiazhuang 050051, China; Hebei Provincial Key Laboratory of Cerebral Networks and Cognitive Disorders, Hebei General Hospital, Shijiazhuang 050051, China.
  • Department of Neurology, Hebei Medical University, Shijiazhuang 050017, China.
  • Department of Neurology, Hebei General Hospital, Shijiazhuang 050051, China.

Zitieren

APA

Xiao, Y., Guan, T., Yang, X., Xu, J., Zhang, J., Qi, Q., Teng, Z., Dong, Y., Gao, Y., Li, M., Meng, N., & Lv, P. (2023). Baicalin facilitates remyelination and suppresses neuroinflammation in rats with chronic cerebral hypoperfusion by activating Wnt/β-catenin and inhibiting NF-κB signaling. Behavioural Brain Research, 442, 114301. https://doi.org/10.1016/j.bbr.2023.114301

Vancouver

Xiao Y, Guan T, Yang X, Xu J, Zhang J, Qi Q, et al. Baicalin facilitates remyelination and suppresses neuroinflammation in rats with chronic cerebral hypoperfusion by activating Wnt/β-catenin and inhibiting NF-κB signaling. Behavioural Brain Research. 2023;442:114301. doi:10.1016/j.bbr.2023.114301

BibTeX
@article{Xiao2023,
  author = {Xiao, Yining and Guan, Tianyuan and Yang, Xiaofeng and Xu, Jing and Zhang, Jiawei and Qi, Qianqian and Teng, Zhenjie and Dong, Yanhong and Gao, Yaran and Li, Meixi and Meng, Nan and Lv, Peiyuan},
  title = {Baicalin facilitates remyelination and suppresses neuroinflammation in rats with chronic cerebral hypoperfusion by activating Wnt/β-catenin and inhibiting NF-κB signaling},
  journal = {Behavioural Brain Research},
  year = {2023},
  volume = {442},
  pages = {114301},
  doi = {10.1016/j.bbr.2023.114301}
}
Kostenlos starten →